Jai Pharma

Jai Pharma Limited was an Indian pharmaceutical company specializing in the development and manufacture of hormonal therapies and active pharmaceutical ingredients (APIs). Based in Mumbai, the company established a significant presence in the production of oral contraceptives and hormone replacement treatments, with a portfolio featuring key substances such as desogestrel, ethinyl estradiol, and levonorgestrel. The company operated manufacturing facilities with international certifications, including EU-GMP and US-FDA, catering to both domestic and global markets. Following a period of strategic growth, Jai Pharma's operations were amalgamated into Mylan Laboratories Limited (now part of Viatris), integrating its specialized manufacturing assets into a larger global network.